Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

More documents

Recommendations

Info

Early-Stage Non–Small-Cell Lung Cancer. J Clin Oncol, 2553-2562, 2009.634 - Yang WYang W, Fu Z, Yu J, Yuan S, Zhang B, Li D, et al. Value of PET/CT versus enhanced CT for locoregionallymph nodes in non-small cell lung cancer. Lung Cancer 61:35-43, 2008.635 - Yasufuku KYasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K, Hiroshima K, et al. Comparison of endobronchialultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest;130:710-718, 2006.636 - Yasumoto KYasumoto K, Osaki T, Watanabe Y, Kato H, Yoshimura T. Prognostic value of cytokeratin-positive cells inthe bone marrow and lymph nodes of patiënts with resected nonsmall cell lung cancer: a multicenterprospective study. Ann Thorac Surg 76:194-201, 2003; discussion 202.637 - Yatsuyanagi EYatsuyanagi E, Hirata S, Yamazaki K, Sasajima T, Kubo Y. Anastomotic complications after bronchoplasticprocedures for nonsmall cell lung cancer. Ann Thorac Surg 70:396-400, 2000.638 - Yoshikawa KYoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T and Mori T. Prospective study of extendedsegmentectomy for small lung tumors: the final report. Ann Thorac Surg 73:1055-1059, 2002.639 - Younes RNYounes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest115:1494-499, 1999.640 - Yun MYun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesionsdetected on CT or MRI. J Nucl Med 42:1795-1799, 2001.641 - Zabora JZabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychologicaldistress by cancer site. Psycho-oncology 10:19-28, 2001.642 - Zakowski MFZakowski MF, Ladanyi M, Kris MG. EGFR mutations in small-cell lung cancers in patiënts who have neversmoked [letter]. N Engl J Med 355:213-215, 2006.643 - Zatloukal PZatloukal P, Petruzelka L, Zemanova M, et al. Concomitant versus sequential chemoradiotherapy withcisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer46: 87-98, 2004.644 - Zeiher BGZeiher BG, Gross TJ, Kern JA, Lanza LA, Peterson MW. Predicting postoperative pulmonary function inpatiënts undergoing lung resection. Chest 108:68-72, 1995.645 - Zhu CQZhu CQ, da Cunha Santos G, Ding K, et al. Role of KRAS and EGFR as biomarkers of response toerlotinib in National Cancer Institute of Canada Clinical Trials Group study BR. 21. J Clin Oncol26:4268–4275, 2008.646 - Zieren HUZieren HU, Muller JM, Petermann D, Pichlmaier H. [The effectiveness of standardized follow-up studiesafter resection of non-small cell bronchial carcinoma]. Langenbecks Arch Chir 379:299-306, 1994.647 - Gibbs A.R.Richtlijn: Niet-kleincellig longcarcinoom (2.0)06/09/2011 Niet-kleincellig longcarcinoom (2.0) 141
Richtlijn: Niet-kleincellig longcarcinoom (2.0)Gibbs AR, Attanoos RL. Examination of lung specimens. J Clin Path 53:507-512, 2000.06/09/2011 Niet-kleincellig longcarcinoom (2.0) 142
Page 6 and 7:
ScreeningLiteratuurbespreking:De wa
Page 8 and 9:
DiagnostiekLiteratuurbespreking:Dit
Page 10 and 11:
Richtlijn: Niet-kleincellig longcar
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
komen in aanmerking voor een medias
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
PathologiediagnostiekUitgangsvraagW
Page 26 and 27:
Page 28 and 29:
Resectabel en lokaal uitgebreid NSC
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
2.Richtlijn: Niet-kleincellig longc
Page 38 and 39:
cytologischonderzoek(depschrapprepa
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Systemische behandeling stadium III
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
de progressievrije overleving en ee
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Palliatieve zorgLiteratuurbesprekin
Page 70 and 71:
Voorlichting en communicatieLiterat
Page 72 and 73:
Nacontrole en nazorgAanbevelingen:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
PatiëntendossierRichtlijn: Niet-kl
Page 84 and 85:
BehandelingOver de behandeling die
Page 86 and 87:
Rol van de verpleegkundigeRichtlijn
Page 88 and 89:
Page 90 and 91:
TNM classificatieAanbevelingen:De n
Page 92 and 93:
1. Pleurale en pericardiale effusie
Page 94 and 95: Richtlijn: Niet-kleincellig longcar
Page 96 and 97: Referenties1 - A. AupérinA. Aupér
Page 98 and 99: 26 - Asamura HAsamura H, Naruke T,
Page 102 and 103: Cappuzzo F, Marchetti A, Skokan M,
Page 112 and 113: comparative analysis of positron em
Page 116 and 117: accuracy and quality control. Am J
Page 136 and 137: cancer and brain metastases. J Clin
Page 142 and 143: lung cancer: A secondary analysis o
Page 146 and 147: Bijlagen1. Betrokken verenigingenIn
Page 148 and 149: • Hr. drs. H.E. Codrington, longa
Page 150 and 151: aanbevolen bijNSCLC-patiënten,stad
Page 152 and 153: med 090318 vr1 diagnostiek PET etc
Page 158 and 159: Mackillop vergelijkend (tussen alle
Page 160: DisclaimerDisclaimer:De informatie
show all

Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?